HomePRQR • NASDAQ
ProQR Therapeutics NV
$2.29
After Hours:
$2.25
(1.74%)-0.040
Closed: Mar 28, 5:05:44 PM GMT-4 · USD · NASDAQ · Disclaimer
StockUS listed security
Previous close
$2.38
Day range
$2.23 - $2.47
Year range
$1.11 - $3.29
Market cap
186.23M USD
Avg Volume
211.99K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
(EUR)Dec 2023Y/Y change
Revenue
3.28M171.18%
Operating expense
12.48M-8.69%
Net income
-5.48M58.77%
Net profit margin
-166.9684.79%
Earnings per share
-0.0856.21%
EBITDA
-9.03M26.38%
Effective tax rate
-0.09%
Total assets
Total liabilities
(EUR)Dec 2023Y/Y change
Cash and short-term investments
118.92M25.48%
Total assets
137.88M-19.52%
Total liabilities
96.49M-7.79%
Total equity
41.39M
Shares outstanding
81.35M
Price to book
4.67
Return on assets
-16.43%
Return on capital
-35.73%
Net change in cash
(EUR)Dec 2023Y/Y change
Net income
-5.48M58.77%
Cash from operations
-5.32M70.16%
Cash from investing
5.00M26,215.79%
Cash from financing
-1.09M-107.93%
Net change in cash
-1.63M71.23%
Free cash flow
14.20M119.26%
About
ProQR Therapeutics NV is a Dutch biotechnology company based in Leiden, the Netherlands, with a presence in Cambridge, Massachusetts, US. The company was funded in 2012 by chief executive officer Daniel A. de Boer. It specializes in the development of RNA therapeutics using its RNA editing platform technology called Axiomer. Wikipedia
Founded
2012
Website
Employees
157
Discover more
You may be interested in
This list is generated from recent searches, followed securities, and other activity. Learn more

All data and information is provided “as is” for personal informational purposes only, and is not intended to be financial advice nor is it for trading purposes or investment, tax, legal, accounting or other advice. Google is not an investment adviser nor is it a financial adviser and expresses no view, recommendation or opinion with respect to any of the companies included in this list or any securities issued by those companies. Please consult your broker or financial representative to verify pricing before executing any trades. Learn more
People also search for
Search
Clear search
Close search
Google apps
Main menu